 |
|
cannabis-based oromucosal spray GW-1000-02
An herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity. Cannabis-based oromucosal spray GW-1000-02 contains a standardized extract of tetrahydrocannabinol (THC), the non-psychoactive cannabinoid cannabidiol (CBD), other minor cannabinoids, flavonoids, and terpenes from two cannabis plant varieties. Cannabinoids interact with G protein-coupled cannabinoid 1 (CB1) receptors in the central nervous system, resulting in analgesic, euphoric, and anticonvulsive effects.
Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Foreign brand name: | | Sativex | | | | Code name: | | GW-1000-02 | | |
|
|
